{
    "key": "2013-0206",
    "name": "Dose 1 to dose 3 interval 16 weeks-4 days. Series complete. ",
    "cdcTestId": "2013-0206",
    "changedInVersion": "1.0",
    "dateAdded": "2013-01-01T00:00:00",
    "dateUpdated": "2020-06-18T08:01:31.106",
    "evaluation": {
        "administeredDoses": [
            {
                "cvx": "08",
                "dateAdministered": "2020-04-27T00:00:00",
                "evaluationReason": "",
                "evaluationStatus": "Valid",
                "mvx": "MSD",
                "vaccineName": "RECOMBIVAX-PEDS"
            },
            {
                "cvx": "08",
                "dateAdministered": "2020-06-20T00:00:00",
                "evaluationReason": "",
                "evaluationStatus": "Valid",
                "mvx": "MSD",
                "vaccineName": "RECOMBIVAX-PEDS"
            },
            {
                "cvx": "08",
                "dateAdministered": "2020-08-13T00:00:00",
                "evaluationReason": "",
                "evaluationStatus": "Valid",
                "mvx": "MSD",
                "vaccineName": "RECOMBIVAX-PEDS"
            }
        ],
        "seriesStatus": "Complete"
    },
    "evaluationTestType": "Interval: At Absolute Minimum",
    "forecast": {
        "earliestDate": "0001-01-01T00:00:00",
        "forecastNum": "-",
        "pastDueDate": "0001-01-01T00:00:00",
        "recommendedDate": "0001-01-01T00:00:00"
    },
    "forecastTestType": "Not recommended: series complete",
    "generalDescription": "This test case describes when dose #3 of the Hep B vaccine is administered at an interval of 16 weeks - 4 days from dose #1 that the dose is considered to be valid.  The series is complete.",
    "patient": {
        "dob": "2020-01-29T00:00:00",
        "gender": "F",
        "medHistoryCode": "",
        "medHistoryCodeSys": "",
        "medHistoryText": "",
        "doses": [
            {
                "cvx": "08",
                "dateAdministered": "2020-04-27T00:00:00",
                "evaluationReason": "",
                "evaluationStatus": "Valid",
                "mvx": "MSD",
                "vaccineName": "RECOMBIVAX-PEDS"
            },
            {
                "cvx": "08",
                "dateAdministered": "2020-06-20T00:00:00",
                "evaluationReason": "",
                "evaluationStatus": "Valid",
                "mvx": "MSD",
                "vaccineName": "RECOMBIVAX-PEDS"
            },
            {
                "cvx": "08",
                "dateAdministered": "2020-08-13T00:00:00",
                "evaluationReason": "",
                "evaluationStatus": "Valid",
                "mvx": "MSD",
                "vaccineName": "RECOMBIVAX-PEDS"
            }
        ]
    },
    "reasonForChange": "",
    "testcaseName": "Dose 1 to dose 3 interval 16 weeks-4 days. Series complete. ",
    "vaccineGroup": "HepB"
}